Gege Qian

Gege Qian

Auto-generated profile, based on publicly available information

Gege Qian

Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA; Department of Medicine, University of California San Diego, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Nature
Verified
Journal Article
Open access
LSLeah V. Schaffer
Leah V. Schaffer
MHMengzhou Hu
Mengzhou Hu
GQGege Qian
Gege Qian
KMKyung-Mee Moon
Kyung-Mee Moon
APAbantika Pal
Abantika Pal
TITrey Ideker
Trey Ideker
Human cells consist of a complex hierarchy of components, many of which remain unexplored1,2. Here we construct a global map of human subcellular architecture through joint measurement of biophysical interactions and immunofluorescence images for over 5,100 proteins in U2OS osteosarcoma cells. Self-supervised multimodal data integration resolves 275 molecular assemblies spanning the range of 10−8 to 10−5 m, which we validate systematically using whole-cell size-exclusion chromatography and annotate using large language models3. We explore key applications in structural biology, yielding structures for 111 heterodimeric complexes and an expanded Rag–Ragulator assembly. The map assigns unexpected functions to 975 proteins, including roles for C18orf21 in RNA processing and DPP9 in interferon signalling, and identifies assemblies with multiple localizations or cell type specificity. It decodes paediatric cancer genomes4, identifying 21 recurrently mutated assemblies and implicating 102 validated new cancer proteins. The associated Cell Visualization Portal and Mapping Toolkit provide a reference platform for structural and functional cell biology.

6 February 2023 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
ASAvinash Sahu
Avinash Sahu
XWXiaoman Wang
Xiaoman Wang
PMPhillip Munson
Phillip Munson
JKJan P.G. Klomp
Jan P.G. Klomp
XWXiaoqing Wang
Xiaoqing Wang
KFKeith T. Flaherty
Keith T. Flaherty
Drugs that kill tumors through multiple mechanisms have the potential for broad clinical benefits. Here, we first developed an in silico multiomics approach (BipotentR) to find cancer cell–specific regulators that simultaneously modulate tumor immunity and another oncogenic pathway and then used it to identify 38 candidate immune–metabolic regulators. We show the tumor activities of these regulators stratify patients with melanoma by their response to anti–PD-1 using machine learning and deep neural approaches, which improve the predictive power of current biomarkers. The topmost identified regulator, ESRRA, is activated in immunotherapy-resistant tumors. Its inhibition killed tumors by suppressing energy metabolism and activating two immune mechanisms: (i) cytokine induction, causing proinflammatory macrophage polarization, and (ii) antigen-presentation stimulation, recruiting CD8+ T cells into tumors. We also demonstrate a wide utility of BipotentR by applying it to angiogenesis and growth suppressor evasion pathways. BipotentR (http://bipotentr.dfci.harvard.edu/) provides a resource for evaluating patient response and discovering drug targets that act simultaneously through multiple mechanisms. Significance: BipotentR presents resources for evaluating patient response and identifying targets for drugs that can kill tumors through multiple mechanisms concurrently. Inhibition of the topmost candidate target killed tumors by suppressing energy metabolism and effects on two immune mechanisms. This article is highlighted in the In This Issue feature, p. 517

2 October 2025 in Nature
Verified
Journal Article
Open access
PDF file
LSLeah V. Schaffer
Leah V. Schaffer
MHMengzhou Hu
Mengzhou Hu
GQGege Qian
Gege Qian
KMKyung-Mee Moon
Kyung-Mee Moon
APAbantika Pal
Abantika Pal
TITrey Ideker
Trey Ideker

22 July 2026 in Cell Reports Methods
Verified
Journal Article
Open access
GQGege Qian
Gege Qian
JKJoonwon Kim
Joonwon Kim
RTRicha Tiwari
Richa Tiwari
BPBenjamin J. Polacco
Benjamin J. Polacco
AFAntoine Forget
Antoine Forget
ACAlejandro Chavez
Alejandro Chavez
Multimodal mapping of subcellular protein organization through imaging and interaction proteomics has been mostly confined to large consortia, owing to high per-target costs, reliance on target-specific antibodies or libraries of epitope-tagged cDNAs, and the lack of unified pipelines for coordinated data acquisition. Here, we present HIT-MAP (high-throughput integrated tagging for cell mapping), an end-to-end framework that couples endogenous epitope tagging with optimized wide-field immunofluorescence imaging and affinity purification-mass spectrometry (AP-MS). Applied to a pilot set of 16 representative proteins in HEK293T cells, HIT-MAP recovers 576 high-confidence protein-protein interactions, identifies canonical complexes, and resolves cross-modality protein communities. Integrative analysis identifies CCDC12 as a previously uncharacterized component of the Bact spliceosomal complex, supported by AP-MS interaction data, tag-free size-exclusion chromatography-mass spectrometry (SEC-MS) co-fractionation, and Perturb-seq transcriptional signatures. HIT-MAP lowers technical and economic barriers to generating coordinated multimodal protein maps.

3 September 2025
Verified
Dataset
Closed access
GQGege Qian
Gege Qian
BioStudies – one package for all the data supporting a study